127 related articles for article (PubMed ID: 11956544)
1. Neck mass as primary manifestation of multiple myeloma originating in the thyroid cartilage.
Gross M; Eliashar R; Petrova P; Goldfarb A; Sichel JY
Otolaryngol Head Neck Surg; 2002 Mar; 126(3):326-8. PubMed ID: 11956544
[No Abstract] [Full Text] [Related]
2. Acute leukemia of plasmablastic type as terminal phase of multiple myeloma.
Piccinini L; Artusi T; Bonacorsi G; Arigliano V
Haematologica; 2002 Feb; 87(2):EIM04. PubMed ID: 11836178
[No Abstract] [Full Text] [Related]
3. [Improved prognosis of generalized AL-amyloidosis in a patient with multiple myeloma treated according to the VAD protocol].
Sarkisova IA; Rameev VV; Kozlovskaia LV; Andreeva NE
Ter Arkh; 2003; 75(8):81-2. PubMed ID: 14520860
[No Abstract] [Full Text] [Related]
4. Bulbar palsy in multiple myeloma.
Chim CS; Ooi GC
Haematologica; 2005 Dec; 90(12 Suppl):ECR42. PubMed ID: 16464757
[No Abstract] [Full Text] [Related]
5. [IgM-lambda multiple myeloma presenting with systemic amyloidosis].
Higeta D; Yokohama A; Osaki Y; Tahara K; Mawatari M; Sekigami T; Koiso H; Saito T; Uchiumi H; Handa H; Karasawa M; Murakami H; Hirato J; Tsukamoto N; Nojima Y
Rinsho Ketsueki; 2009 Dec; 50(12):1711-4. PubMed ID: 20068279
[TBL] [Abstract][Full Text] [Related]
6. A phase II study of liposomal doxorubicin, vincristine and dexamethasone in multiple myeloma.
Hönemann D; Prince HM; Seymour JF; Wolf MM; Westerman D; Januszewicz EH
Leuk Lymphoma; 2005 Jun; 46(6):945-7. PubMed ID: 16019544
[No Abstract] [Full Text] [Related]
7. Alternating combination of alkylating agents and vincristine, doxorubicin, and dexamethasone in multiple myeloma.
Lejeune C; Sotto JJ; Fuzibet JG; Rossi JF; Lepeu G; Bataille R
J Clin Oncol; 1991 Jun; 9(6):1090-1. PubMed ID: 2033423
[No Abstract] [Full Text] [Related]
8. Long-term remission of paraprotein-induced immunotactoid glomerulopathy after high-dose therapy and autologous blood stem cell transplantation.
Witzens-Harig M; Waldherr R; Beimler J; Zeier M; Hansmann J; Ho AD; Goldschmidt H; Moehler T
Ann Hematol; 2007 Dec; 86(12):927-30. PubMed ID: 17605010
[No Abstract] [Full Text] [Related]
9. [Multiple myeloma complicated with Takotsubo cardiomyopathy].
Mitsumori T; Nakajima K; Nozaki Y; Hamanaka S; Nagashima T; Kirito K; Iwao N; Komatsu N
Rinsho Ketsueki; 2010 Apr; 51(4):291-6. PubMed ID: 20467228
[TBL] [Abstract][Full Text] [Related]
10. Transient severe symptomatic pulmonary hypertension as onset symptom in multiple myeloma.
Rostagno C; Ciolli S
Ann Hematol; 2006 Sep; 85(9):627-8. PubMed ID: 16705455
[No Abstract] [Full Text] [Related]
11. Hodgkin's lymphoma as a second cancer in multiple myeloma never exposed to lenalidomide.
Chim CS; Choi PT; Lee WK
Ann Hematol; 2013 Jun; 92(6):855-7. PubMed ID: 23183880
[No Abstract] [Full Text] [Related]
12. [Pneumonia caused by Salmonella in a patient with myeloma].
Fernández P; Roldán V; García MC; Gil MT; Rivas C
Sangre (Barc); 1995 Jun; 40(3):234-5. PubMed ID: 7570286
[No Abstract] [Full Text] [Related]
13. Chemotherapy of resistant multiple myeloma with vincristine, adriamycin and dexamethasone (VAD).
Maniatis A; Stamatellou M; Papanastasiou K
Chemioterapia; 1987 Jun; 6(2 Suppl):727-8. PubMed ID: 3509532
[No Abstract] [Full Text] [Related]
14. Melphalan-prednisolone and vincristine-doxorubicin-dexamethasone chemotherapy followed by prednisolone/interferon maintenance therapy for multiple myeloma: Japan Clinical Oncology Group Study, JCOG0112.
Chou T; Tobinai K; Uike N; Asakawa T; Saito I; Fukuda H; Mizoroki F; Ando K; Iida S; Ueda R; Tsukasaki K; Hotta T;
Jpn J Clin Oncol; 2011 Apr; 41(4):586-9. PubMed ID: 21247967
[TBL] [Abstract][Full Text] [Related]
15. Successful treatment of multiple myeloma--associated amyloidosis by interferon-alpha, dimethyl sulfoxide, and VAD (vincristine, adriamycin, and dexamethasone).
Ichida M; Imagawa S; Ohmine K; Komatsu N; Hatake K; Ozawa K; Miura Y
Int J Hematol; 2000 Dec; 72(4):491-3. PubMed ID: 11197218
[TBL] [Abstract][Full Text] [Related]
16. Combination chemotherapy with vincristine, doxorubicin, dexamethasone for refractory or relapsing multiple myeloma.
Monconduit M; Le Loet X; Bernard JF; Michaux JL
Br J Haematol; 1986 Jul; 63(3):599-601. PubMed ID: 3730288
[No Abstract] [Full Text] [Related]
17. [Treatment of multiple myeloma resistant to alkylating agents with dexamethasone, vincristine and adriamycin in continuous infusion].
Monconduit M; Le Loët X; Bernard JF; Menard JF; Grosbois B; Michaux JL; De Gramont A; Laporte JP; Najman A; Jouet JP
Rev Rhum Mal Osteoartic; 1987 Jun; 54(6):477-9. PubMed ID: 3616472
[No Abstract] [Full Text] [Related]
18. High dose simvastatin does not reverse resistance to vincristine, adriamycin, and dexamethasone (VAD) in myeloma.
van der Spek E; Bloem AC; Sinnige HA; Lokhorst HM
Haematologica; 2007 Dec; 92(12):e130-1. PubMed ID: 18055977
[TBL] [Abstract][Full Text] [Related]
19. [Results of treatment of patients with advanced multiple myeloma with the vincristine-adriamycin-dexamethasone protocol].
Marisavljević D; Bosković D; Radosević N; Elezović I; Tomin D; Gotić M; Antunović P
Srp Arh Celok Lek; 1996; 124(11-12):292-6. PubMed ID: 9132962
[TBL] [Abstract][Full Text] [Related]
20. Is double autologous stem-cell transplantation appropriate for new multiple myeloma patients?
van Rhee F
Nat Clin Pract Oncol; 2008 Feb; 5(2):70-1. PubMed ID: 17984985
[No Abstract] [Full Text] [Related]
[Next] [New Search]